MCHS FRANCISCAN HEALTHCARE INC
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1M
- Transactions
- 299
- Companies
- 24
- Average per transaction
- $3,457
Who reported the payments
| AstraZeneca | $554,725 |
| Bristol Myers Squibb | $130,350 |
| Esperion Therapeutics, Inc. | $105,205 |
| Shire North American Group Inc | $67,750 |
| Kowa Research Institute, Inc. | $38,814 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29,350 |
| B. Braun Medical Inc. | $28,940 |
| Astrazeneca UK Limited | $19,441 |
| Johnson & Johnson | $19,437 |
| Stryker | $12,037 |
| Boehringer Ingelheim | $9,417 |
| Olympus America Inc. | $8,510 |
| Aesculap Biologics, LLC | $3,750 |
| Actelion Pharmaceuticals US, Inc. | $2,000 |
| Kls-martin L.p. | $1,616 |
| Novo Nordisk | $750 |
| Organon | $700 |
| Leica Microsystems Inc. | $430 |
| Cochlear Americas | $194 |
| Fisher & Paykel Healthcare Inc | $189 |
| Lantheus Medical Imaging, Inc. | $68 |
| Baxter Healthcare | $33 |
| Allen Medical Systems | $27 |
| Janssen Research & Development, LLC | $12 |